)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Summit Therapeutics
Summit Therapeutics (SMMT) investor relations material
Summit Therapeutics Proxy filing summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Proxy filing summary19 Oct, 2026
Executive summary
Special meeting scheduled virtually for November 4, 2026; record date October 1, 2026, with 799,726,418 common shares outstanding and entitled to vote.
Stockholders will vote on raising authorized common shares by 1 billion, from 1 billion to 2 billion; the board unanimously recommends approval.
Voting matters and shareholder proposals
Proposal 1 requires approval by a majority of votes cast; abstentions and broker non-votes have no effect, and brokers may vote uninstructed shares because the proposal is routine.
Votes by Internet or telephone are due by 11:59 p.m. ET November 3, 2026; stockholders may also vote during the virtual meeting.
Rule 14a-8 proposals for the 2027 annual meeting must be received by December 18, 2026; advance-notice and universal-proxy deadlines also apply to nominations and other business.
Board of directors and corporate governance
The board unanimously adopted the charter amendment as advisable and in stockholders’ best interests, and recommends a FOR vote.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Summit Therapeutics
- A 1 billion-share authorization increase is tied to a $2 billion preferred financing.SMMT
Proxy filing - Ivonescimab's phase III successes position it as a potential game changer in solid tumor therapy.SMMTThe Citizens Life Sciences Conference 2026
- Ivonescimab achieved landmark Phase III survival results, FDA BLA acceptance, and strong cash reserves.SMMTQ2 2026
- Ivonescimab shows superior efficacy and safety in NSCLC, driving global phase III trials.SMMTCiti's 2024 Global Healthcare Conference
- Ivonescimab's global trials show strong efficacy, with pivotal filings and new indications advancing.SMMTJefferies London Healthcare Conference 2025
- Ivonescimab plus chemo cut death risk by 34% vs. tislelizumab in 1L squamous NSCLC.SMMTStatus update
- Ivonescimab's strong phase III data drive BLA plans, but urgent new funding is needed.SMMTQ3 2025
- Ivonescimab's strong Phase III results and $487M cash drive global clinical expansion.SMMTQ3 2024
- Ivonescimab's PFS benefit and China approval drive global trials, with $361M cash and no debt.SMMTQ1 2025
Next Summit Therapeutics earnings date
Q3 202626 Oct, 2026
Summit Therapeutics
Next Summit Therapeutics earnings date
Q3 202626 Oct, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Explore our global coverage